Last update:
Medications news
Medications
FDA approves Ebglyss for moderate-to-severe atopic dermatitis
The U.S. Food and Drug Administration has approved Eli Lilly's Ebglyss (lebrikizumab-lbkz) for adults and children aged 12 years and older with moderate-to-severe atopic dermatitis.
11 minutes ago
0
0
Medications
Weight loss drugs could help fight fatty liver disease
In the fight against fatty liver disease, researchers are looking for any and all possible solutions. But to combat the disease, which is also known as metabolic dysfunction-associated steatotic liver disease, or MASLD, scientists ...
19 hours ago
0
33
The most effective migraine drugs should be promoted globally and guidelines updated accordingly, say researchers
Some triptans are a more effective treatment for acute migraines than newer, more expensive drugs, finds an analysis of the latest evidence published in The BMJ.
12 hours ago
0
3
Severe side effects of the most effective schizophrenia medication identified
About one-third of patients with schizophrenia do not respond to conventional medications, leaving them with one effective treatment option: clozapine. Clozapine's most serious side effect, a life-threatening drop in white ...
15 hours ago
0
1
FDA expands use of breast cancer drug Kisqali
Women with early stage breast cancer may now take Kisqali, a medication already approved for advanced disease, following the U.S. Food and Drug Administration's expanded approval of the treatment, drug maker Novartis announced ...
21 hours ago
0
1
Some people with MS may need earlier, higher-dose meds, study shows
Early, aggressive treatment of brain lesions caused by multiple sclerosis could help ward off faster decline in patients, a new study finds.
21 hours ago
0
0
Studies indicate no major concerns about risks to offspring for would-be dads taking epilepsy meds
Would-be dads taking drugs to stop their epilepsy seizures—and valproate in particular—should be largely reassured that the available evidence on the developmental risks to their offspring doesn't justify any major concerns, ...
Sep 17, 2024
0
0
Ultra-low-dose ketamine can curb opioid withdrawal
Drug overdose is the leading cause of injury deaths in young adults in the United States, with fentanyl causing over 70,000 deaths annually.
Sep 17, 2024
0
1
Health care app could help improve medication safety
Around 75% of Australians have experienced a bad reaction to a medication, but fewer than half have reported it to a doctor or the Therapeutic Goods Administration (TGA), a new survey has found.
Sep 17, 2024
0
0
Why is it so hard to get drugs approved for use during pregnancy?
Nobody wants to see another Thalidomide tragedy.
Sep 17, 2024
0
0
Survey shows 25% of adults consider weight loss drug use without prescription
Injectable weight loss drugs are popular right now but can be hard to get because they are in short supply or too expensive without insurance. The result is that some people are skipping the doctor's office and reaching out ...
Sep 17, 2024
0
0
Experimental drug helps cancer patients regain weight, study shows
Pfizer Inc.'s experimental drug for cancer weight loss was shown to help patients regain weight in a mid-stage study, offering fresh promise for treating the dangerous muscle-wasting condition.
Sep 16, 2024
0
24
Generative AI model study shows no racial or sex differences in opioid recommendations for treating pain
A study from Mass General Brigham researchers provides evidence that large language models (LLMs), used for generative artificial intelligence (AI), ChatGPT-4 and Google's Gemini, demonstrated no differences in suggested ...
Sep 16, 2024
0
16
Ozempic could curb progression of diabetes-linked liver disease
Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic can help stop that.
Sep 16, 2024
0
11
Targeted radioactive infusion for late-stage prostate cancer shown to improve outcomes for patients in earlier stages
A targeted radioactive infusion that is a game-changer in late-stage prostate cancer can also dramatically improve outcomes for patients in earlier stages of this disease, a Peter Mac-led study has shown.
Sep 16, 2024
0
0
Team publishes results from clinical trial evaluating cabozantinib in advanced neuroendocrine tumors
The Alliance for Clinical Trials in Oncology today announced that final results will be presented at ESMO 2024 from CABINET (A021602), a phase III trial evaluating cabozantinib compared with placebo in two cohorts of patients ...
Sep 16, 2024
0
0
Researchers announce clinical trial results for hard-to-treat breast and bladder cancers
Professors Tom Powles and Peter Schmid recently delivered results from their phase three clinical trials during Sunday's Presidential Symposium to over 30,000 attendees at the European Society for Medical Oncology (ESMO) ...
Sep 16, 2024
0
0
Need medicine in hospital? Study finds how often IT flaws lead to the wrong drug or dose
Every time you are prescribed medicine in hospital, a computer will prompt your doctor about the appropriateness of the medicine and its dose.
Sep 14, 2024
0
3
Metformin found to reduce organ aging in male monkeys
A team of biologists affiliated with multiple institutions in China, working with a colleague in the U.S., has found that giving cynomolgus monkeys the diabetes drug metformin can reduce aging in multiple organs, including ...
Key factors identified that can impact long-term weight loss in patients with obesity prescribed GLP-1 RA medications
A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or obesity. ...
Sep 13, 2024
0
0
Antidepressants prescribed for pain in older adults despite weak evidence of effectiveness
University of Sydney research has found people over 65 are being prescribed antidepressants as pain treatment based on international guidelines that use limited evidence. The paper is published in the British Journal of Clinical ...
Sep 13, 2024
0
0
2017 to 2022 saw increase in naloxone prescribing among adolescents, research shows
From 2017 to 2022, there was an increase in naloxone prescribing among adolescents, with pediatricians accounting for an increasing proportion of prescriptions dispensed, according to a study published online Sept. 12 in ...
Sep 13, 2024
0
0
Which gut drugs might end up in a lawsuit? Are there really links with cancer and kidney disease?
Common medicines used to treat conditions including heartburn, reflux, indigestion and stomach ulcers may be the subject of a class action lawsuit in Australia.
Sep 12, 2024
0
1
Aussies with type 2 diabetes are missing out on crucial meds, says study
UNSW medical researchers say more Australians with type 2 diabetes need to be offered add-on medications that would better protect them from heart and kidney disease—which are among the major causes of death for people ...
Sep 12, 2024
0
4
Reductions seen in benzodiazepine dispensing when states relax medical, recreational cannabis access
A small team of mental and public policy specialists from the Georgia Institute of Technology, the University of Georgia and Indiana University has found that when states relax or rescind laws governing the use of marijuana, ...
